Response Genetics' Q1 Revenues Jump 140 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics this week reported first-quarter 2010 revenue growth of 140 percent, driven by its Response DX test sales.

The Los Angeles, Calif.-based molecular diagnostics firm had total revenues of $3.7 million for the three-month period ended March 31, compared to $1.5 million for the first quarter of 2009. It said that sales of its Response DX genetic tests rose to $1.72 million from $263,000 for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.